Inari Medical, Inc. Equity Securities without Readily Determinable Fair Value, Amount
Inari Medical, Inc. had Equity Securities without Readily Determinable Fair Value, Amount of $1.50 million as of 2024-09-30, per its 10-Q filed 2024-10-28.
Financial Statements › Notes › Debt and Equity Securities
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount · last filed 2024-10-28
- 2024-09-30: Equity Securities without Readily Determinable Fair Value, Amount $1.50M.
- 2024-06-30: Equity Securities without Readily Determinable Fair Value, Amount $1.50M.
- 2024-03-31: Equity Securities without Readily Determinable Fair Value, Amount $1.50M.
- 2023-12-31: Equity Securities without Readily Determinable Fair Value, Amount $1.50M.
| Period end | Equity Securities without Readily Determinable Fair Value, Amount |
|---|---|
| 2024-09-30 | $1.50M 10-Q · filed 2024-10-28 |
| 2024-06-30 | $1.50M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $1.50M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $1.50M 10-Q · filed 2024-10-28 |
| 2023-09-30 | $8.30M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $8.80M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $8.60M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $8.30M 10-K · filed 2024-02-29 |